Zimmer Biomet Officially Enters Growth Era

Zimmer Biomet reported 4Q23 orthopedic sales of $1.9 billion, +6.3% compared to the fourth quarter of 2022. For the full year, the company generated $7.4 billion in orthopedic sales, representing growth of 6.5% compared to the prior year.

The company executed in the face of macro issues in the global markets, but expects those headwinds to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us